PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.
about
The progress of early growth response factor 1 and leukemiaElevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Heparin Mimetics: Their Therapeutic Potential.
P2860
PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
PI-88 inhibits postoperative r ...... aranase after liver resection.
@en
type
label
PI-88 inhibits postoperative r ...... aranase after liver resection.
@en
prefLabel
PI-88 inhibits postoperative r ...... aranase after liver resection.
@en
P2093
P2860
P1433
P1476
PI-88 inhibits postoperative r ...... aranase after liver resection.
@en
P2093
Bo-Yi Liao
Wei-Feng Liu
Zao-Zhuo Shen
Zheng Wang
P2860
P2888
P304
P356
10.1007/S13277-015-4085-8
P577
2015-09-28T00:00:00Z
P6179
1003458763